Crossmark

Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study

Crossref DOI link: https://doi.org/10.1007/s10067-020-05161-w

Published Online: 2020-05-26

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Aran

Kim, Yunkyung

Kim, Geun-Tae

Ahn, Eunyoung

So, Min Wook

Lee, Seung-Geun https://orcid.org/0000-0002-5205-3978
License Information

Text and Data Mining valid from 2020-05-26

Version of Record valid from 2020-05-26
More Information

Article History

Received: 30 March 2020

Revised: 4 May 2020

Accepted: 8 May 2020

First Online: 26 May 2020

Compliance with ethical standards

:

: Ethical approval was obtained via the Research and Ethical Review Board of Pusan National University Hospital, which waived informed consent due to retrospective study design (IRB no. 1912–021-086).

: None.

Document is current

Any future updates will be listed below